☆ 4.4 Editorial Material

Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load

GEROSCIENCE (2022)

Related references

Note: Only part of the references are listed.
Article Immunology

Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India)

Paulo R. S. Sanches et al.

Summary: New variants of SARS-CoV-2 Alpha, Beta, Gamma, and Delta have rapidly spread in various countries, and mutations in the RBD spike protein may lead to increased infectivity compared to the Wuhan 2019 strain.

JOURNAL OF VIRUS ERADICATION (2021)

Add to Collection
Article Virology

Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity

Shang Yu Gong et al.

Summary: Towards the end of 2020, various variants of concern and interest emerged from the original SARS-CoV-2 strain, with a focus on mutations in the Spike protein and their impact on transmissibility, pathogenesis, and vaccine efficacy. Single mutations were found to have differential contributions to the global variants phenotype related to ACE2 interaction and antigenicity, with enhanced ACE2 interaction mainly being modulated by a decrease in off-rate. Additionally, it was observed that the Spike proteins from emerging variants bind better to ACE2 at 37 degrees C compared to the D614G variant.

VIROLOGY (2021)

Add to Collection
Article Microbiology

Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Mutation Hotspots Associated With Clinical Outcomes and Transmission

Xianwu Pang et al.

Summary: Mutations in the SARS-CoV-2 genome are directly associated with clinical outcomes and pandemic, with mutations more likely to occur in mild and severe cases. Mutations associated with asymptomatic cases are mainly found in open reading frame 1ab (ORF1ab) and N genes, while mutations in mild and severe cases are more prevalent.

FRONTIERS IN MICROBIOLOGY (2021)

Add to Collection
Editorial Material Medicine, General & Internal

Variants of SARS-CoV-2

Adam S. Lauring et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection
Article Microbiology

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution

Jiri Zahradnik et al.

Summary: In vitro evolution of the SARS-CoV-2 spike protein receptor-binding domain successfully generated a high-affinity variant effective in inhibiting virus infection. Mutations present in more transmissible viruses were preferentially selected, and increased affinity to ACE2 was positively correlated with the incidence of RBD mutations in the population. The study also identified mutations with potential higher infectivity, and the high-affinity RBD variant showed efficacy in inhibiting infection in vitro and reducing clinical disease in a hamster model of SARS-CoV-2 challenge.

NATURE MICROBIOLOGY (2021)

Add to Collection
Article Infectious Diseases

Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy

Domenico Benvenuto et al.

JOURNAL OF INFECTION (2020)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.